Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001216722 | SCV001388533 | pathogenic | Ehlers-Danlos syndrome, dermatosparaxis type | 2022-10-28 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu19Cysfs*146) in the ADAMTS2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ADAMTS2 are known to be pathogenic (PMID: 10417273). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ADAMTS2-related conditions. ClinVar contains an entry for this variant (Variation ID: 945961). For these reasons, this variant has been classified as Pathogenic. |